Psychiatry and Neurology, Epilepsy · Houston, TX
NPI
1285138255
Since 2018
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6560 Fannin St Ste 802
Houston, TX, 77030
Phone (713) 441-3790
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
291 services
Medicare patients, 2024
196
Average age 73
Drug cost, 2024
$815K
1,570 prescriptions
Company payments, 2025
$1,775
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rohit S Kuruvilla was code 95720 (neurologic), 52 times for 32 patients. In total Rohit S Kuruvilla billed 291 services in 17 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 52 | 32 | $164.42 | $8,550 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 32 | $94.73 | $4,263 |
| 95819 Neurologic | Facility | 37 | 37 | $44.55 | $1,648 |
| 99205 Office E&M - New | Office | 34 | 34 | $177.79 | $6,045 |
| 95816 Neurologic | Facility | 32 | 32 | $44.55 | $1,426 |
| 99222 Hospital E&M - Initial | Facility | 27 | 25 | $104.74 | $2,828 |
| 99215 Office E&M - Established | Office | 26 | 20 | $145.01 | $3,770 |
| 95718 Neurologic | Facility | 16 | 15 | $106.86 | $1,710 |
Medicare prescription drug claims, 2024
In 2024, the drug Rohit S Kuruvilla prescribed most often to Medicare patients was Levetiracetam, with 199 prescriptions and refills. In total Rohit S Kuruvilla wrote 1,570 Medicare prescriptions that cost $815K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 199 | 344 | 51 | $11K |
| Lamotrigine Generic | 134 | 261 | 36 | $2,696 |
| Aptiom Eslicarbazepine Acetate | 85 | 99 | Under 11 | $305K |
| Zonisamide Generic | 84 | 167 | 26 | $5,587 |
| Lacosamide Generic | 75 | 139 | 26 | $23K |
| Carbamazepine Er Carbamazepine | 68 | 116 | 14 | $7,762 |
| Topiramate Generic | 67 | 129 | 17 | $1,899 |
| Lamotrigine Er Lamotrigine | 67 | 158 | 18 | $33K |
| Clonazepam Generic | 55 | 74 | 19 | $694 |
| Briviact Brivaracetam | 51 | 67 | Under 11 | $119K |
| Gabapentin Generic | 51 | 91 | 18 | $994 |
| Oxcarbazepine Generic | 50 | 76 | 13 | $5,568 |
| Carbamazepine Generic | 46 | 62 | Under 11 | $2,870 |
| Divalproex Sodium Generic | 28 | 56 | Under 11 | $1,216 |
| Ethosuximide Generic | 27 | 33 | Under 11 | $1,756 |
Brand drugs: 322 claims; generic drugs: 1,223 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rohit S Kuruvilla $1,775 ($1,775 in general payments such as food, travel and fees) from 10 companies. The largest payer was UCB, Inc. with $498.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 15 | $498 |
| SK Life Science, Inc. | 16 | $434 |
| Jazz Pharmaceuticals Inc. JAZZ | 16 | $392 |
| Aucta Pharmaceuticals, Inc. | 14 | $205 |
| Monteris Medical Corporation | 1 | $132 |
| Catalyst Pharmaceuticals, Inc. CPRX | 2 | $39.47 |
| SpringWorks Therapeutics, Inc. | 1 | $26.62 |
| Pfizer Inc. PFE | 1 | $16.51 |
| Lundbeck LLC | 1 | $16.21 |
| OWP Pharmaceuticals, Inc. | 1 | $14.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.